Trial Outcomes & Findings for To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population (NCT NCT02937636)

NCT ID: NCT02937636

Last Updated: 2019-06-14

Results Overview

The BI was performed by a single examiner using a color coded periodontal probe. The probe was inserted approximately 1 mm into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system to be used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. This measure will be analyzed and summarized over all sites.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

128 participants

Primary outcome timeframe

At Week 12

Results posted on

2019-06-14

Participant Flow

Participants were recruited from one center in China.

A total of 343 participates were screened, out of which 128 participants were randomized in the study. 215 participants were not randomized as 186 participants did not meet study criteria, 5 participants withdrew consent and 24 were not randomized for other reasons (not specified).

Participant milestones

Participant milestones
Measure
Test Product
Participants applied a full strip of dentifrice containing 0.454% weight by weight (w/w) stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 parts per million (ppm) fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Overall Study
STARTED
63
65
Overall Study
COMPLETED
60
63
Overall Study
NOT COMPLETED
3
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Test Product
Participants applied a full strip of dentifrice containing 0.454% weight by weight (w/w) stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 parts per million (ppm) fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Overall Study
Other (Not specified)
3
2

Baseline Characteristics

To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Total
n=128 Participants
Total of all reporting groups
Age, Customized
40.8 Years
STANDARD_DEVIATION 10.20 • n=99 Participants
42.9 Years
STANDARD_DEVIATION 10.04 • n=107 Participants
41.9 Years
STANDARD_DEVIATION 10.13 • n=206 Participants
Sex: Female, Male
Female
51 Participants
n=99 Participants
52 Participants
n=107 Participants
103 Participants
n=206 Participants
Sex: Female, Male
Male
12 Participants
n=99 Participants
13 Participants
n=107 Participants
25 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
63 Participants
n=99 Participants
65 Participants
n=107 Participants
128 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
White
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Stratification n (%)
Male, Smoker, Baseline MGI <= 2.00
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Stratification n (%)
Male, Smoker, Baseline MGI > 2.00
1 Participants
n=99 Participants
1 Participants
n=107 Participants
2 Participants
n=206 Participants
Stratification n (%)
Male, non-smoker, Baseline MGI <= 2.00
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Stratification n (%)
Male, non-smoker, Baseline MGI > 2.00
11 Participants
n=99 Participants
12 Participants
n=107 Participants
23 Participants
n=206 Participants
Stratification n (%)
Female, Smoker, Baseline MGI <= 2.00
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Stratification n (%)
Female, Smoker, Baseline MGI > 2.00
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Stratification n (%)
Female, non-smoker, Baseline MGI <= 2.00
4 Participants
n=99 Participants
3 Participants
n=107 Participants
7 Participants
n=206 Participants
Stratification n (%)
Female, non-smoker, Baseline MGI > 2.00
47 Participants
n=99 Participants
49 Participants
n=107 Participants
96 Participants
n=206 Participants

PRIMARY outcome

Timeframe: At Week 12

Population: The intent to treat (ITT) (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.

The BI was performed by a single examiner using a color coded periodontal probe. The probe was inserted approximately 1 mm into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system to be used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. This measure will be analyzed and summarized over all sites.

Outcome measures

Outcome measures
Measure
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Mean Bleeding Index (BI)
0.07 Score on Scale
Standard Deviation 0.059
0.15 Score on Scale
Standard Deviation 0.128

SECONDARY outcome

Timeframe: At Week 12

Population: The ITT (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.

Number of bleeding sites were measured as BI via a single examiner using a color coded periodontal probe. The probe was gently inserted approximately 1 millimeter (mm) into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system used to measure bleeding sites is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. A bleeding site was considered as a BI score of 1 or 2.

Outcome measures

Outcome measures
Measure
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Number of Bleeding Sites
10.37 Number of bleeding sites
Standard Deviation 8.499
20.92 Number of bleeding sites
Standard Deviation 15.881

SECONDARY outcome

Timeframe: At Week 12

Population: The ITT (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.

The MGI was assessed on facial and lingual surfaces at two sites on each tooth (papillae and margin).The scoring of MGI was performed by a single examiner. The MGI scoring system is as follows:0=absence of inflammation;1=mild inflammation; slight change in color, little change in color; little change in texture of any portion of the marginal or papillary gingival unit;2=mild inflammation; criteria as above but involving the entire marginal or papillar gingival units;3=moderate inflammation; glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingival unit;4=severe inflammation; marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration.

Outcome measures

Outcome measures
Measure
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Mean Modified Gingival Index (MGI)
1.62 Score On Scale
Standard Deviation 0.211
1.89 Score On Scale
Standard Deviation 0.198

SECONDARY outcome

Timeframe: At Week 12

Population: The ITT (n=128) population is defined as those participants who were randomized, received at least one dose of study product and had at least one post-baseline efficacy measurement.

The dental examiner used the PI to assess plaque on all gradable teeth. The plaque was first disclosed using a dye solution. Participants then rinsed with disclosing solution according to instructions. Plaque was assessed with each tooth being divided into 6 areas including the mesiofacial, facial, distofacial, mesiolingual, lingual and distolingual surfaces. Disclosed plaque was scored as follows: 0= No plaque; 1= Slight flecks of plaque at the cervical margin of the tooth; 2= A thin continuous band of plaque (1 mm or smaller) at the cervical margin of the tooth; 3= A band of plaque wider than 1 mm but covering less than 1/3 of the crown of the tooth; 4= Plaque covering at least 1/3 but less tan 2/3 of the crown of the tooth; 5= Plaque covering 2/3 or more of the crown of the tooth.Overall PI score and interproximal PI score were calculated as the mean PI over all tooth sites and mean PI over interproximal sites (distal and mesial) respectively.

Outcome measures

Outcome measures
Measure
Test Product
n=63 Participants
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
n=65 Participants
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Mean Plaque Index (PI) (Overall and Interproximal)
Mean Plaque Index (PI) (overall)
1.85 Score on Scale
Standard Deviation 0.319
2.19 Score on Scale
Standard Deviation 0.245
Mean Plaque Index (PI) (Overall and Interproximal)
Mean Plaque Index (PI) (interproximal)
1.92 Score on Scale
Standard Deviation 0.313
2.24 Score on Scale
Standard Deviation 0.240

Adverse Events

Test Product

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Reference Product

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Test Product
n=63 participants at risk
Participants applied a full strip of dentifrice containing 0.454% w/w stannous fluoride and 0.0721% w/w sodium fluoride containing 1450 ppm fluoride to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Reference Product
n=65 participants at risk
Participants applied a full strip of dentifrice containing 0.14% w/w sodium monofluorophosphate (1400 ppm fluoride) to cover the head of the toothbrush provided and brush their teeth with the assigned dentifrice twice daily (morning and evening) for one timed minute following their normal routine.
Gastrointestinal disorders
SENSITIVITY OF TEETH
1.6%
1/63 • Number of events 1 • 12 Weeks
0.00%
0/65 • 12 Weeks
Gastrointestinal disorders
STOMATITIS
1.6%
1/63 • Number of events 1 • 12 Weeks
0.00%
0/65 • 12 Weeks
Gastrointestinal disorders
APHTHOUS ULCER
0.00%
0/63 • 12 Weeks
1.5%
1/65 • Number of events 1 • 12 Weeks
Infections and infestations
ORAL HERPES
1.6%
1/63 • Number of events 1 • 12 Weeks
0.00%
0/65 • 12 Weeks
Infections and infestations
NASOPHARYNGITIS
0.00%
0/63 • 12 Weeks
1.5%
1/65 • Number of events 1 • 12 Weeks
Infections and infestations
PHARYNGITIS
0.00%
0/63 • 12 Weeks
1.5%
1/65 • Number of events 1 • 12 Weeks

Additional Information

GSK Response Center

GlaxoSmithKline

Phone: 866-435-7343

Results disclosure agreements

  • Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
  • Publication restrictions are in place

Restriction type: OTHER